journal der deutschen dermatologischen gesellschaft = journal of the german society of dermatology : jddg

schweizer archiv fur tierheilkunde

[1] [Vaccinovigilance: Reported adverse reactions of immunological veterinary medicinal products in 2018].

[2] Wirksamkeit des IL-17-Hemmers SECUKINUMAB bei akuter generalisierter exanthematische Pustulose (AGEP).

[3] Die Wirksamkeit der Radiofrequenztherapie mit isolierten Mikronadeln zur Reduktion von hervortretenden infraorbitalen Fettpolstern.

[4] Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine.

[5] Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.

[6] In ovo vaccination of broilers against Campylobacter jejuni using a bacterin and subunit vaccine.

[7] Self-emulsifying drug delivery systems: In vivo evaluation of their potential for oral vaccination.

[8] Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity.

[9] Reply to "HPV vaccine requirements, opt-outs and providers' support: Key studies missing from a recent systematic review".

[10] HPV genotype prevalence and distribution during 2009-2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination.

[11] Emerging Vaccine Informatics

[12] Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review

[13] CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS

[14] Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

[15] Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

[16] Recent advances in Staphylococcus aureus infection: focus on vaccine development

[17] Further considerations on rotavirus vaccination and seizure-related hospitalization rates

[18] Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

[19] Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

[20] A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

[21] Phenotypic and molecular characteristics of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from pigs: implication for livestock-association markers and vaccine strategies

[22] Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

[23] Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

[24] Meningococcal conjugate vaccines: optimizing global impact

[25] Review of oral cholera vaccines: efficacy in young children

[26] Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

[27] Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

[28] CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS

[29] Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

[30] Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

[31] CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS

[32] Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

[33] Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

[34] Immunoinformatics Approach for Multiepitopes Vaccine Prediction against Glycoprotein B of Avian Infectious Laryngotracheitis Virus

[35] Recent advances in Staphylococcus aureus infection: focus on vaccine development

[36] Further considerations on rotavirus vaccination and seizure-related hospitalization rates

[37] Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

[38] Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

[39] A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

[40] Phenotypic and molecular characteristics of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from pigs: implication for livestock-association markers and vaccine strategies

[41] Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

[42] Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

[43] Meningococcal conjugate vaccines: optimizing global impact

[44] Review of oral cholera vaccines: efficacy in young children

[45] Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

[46] Vaccine Prophylaxis of Pneumococcal Infections in Children under Conditions of Severe Flood in the Amur River Basin

[47] Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

[48] Immunological response to Brucella abortus strain 19 vaccination of cattle in a communal area in South Africa

[49] Immunogenicity of a plasmid DNA vaccine encoding G1 epitope of bovine ephemeral fever virus G glycoprotein in mice

[50] Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania

[51] Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study.

[52] The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia

[53] Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal.

[54] At the bench: Engineering the next generation of cancer vaccines.

[55] Minipigs as a neonatal animal model for tuberculosis vaccine efficacy testing.

[56] Paid maternity leave and childhood vaccination uptake: Longitudinal evidence from 20 low-and-middle-income countries.

[57] Immunological efficacy of Vaccination against Measles in Children with Down syndrome

[58] "You need to do your research": Vaccines, contestable science, and maternal epistemology.

[59] Strengths, pitfalls, and lessons learned in implementing electronic collection of childhood vaccination data in Zambia: The SmartCare experience.

[60] Trends in the travelers' demand for pre-travel medical advice at a Spanish International Vaccination Center between 2000 and 2017.

[61] Awareness, perceptions and intent to comply with the prospective malaria vaccine in parts of South Eastern Nigeria.

[62] THE POTENTIAL PUBLIC HEALTH IMPACT OF HERPES ZOSTER VACCINATION IN THE 65 YEARS OF AGE COHORT IN ITALY.

[63] Understanding Public Perceptions of the HPV Vaccination Based on Online Comments to Canadian News Articles.

[64] The art of partnerships for vaccines.

[65] The costs of delivering vaccines in low- and middle-income countries: Findings from a systematic review.

[66] A Scoping Review of Investment Cases for Vaccines and Immunization Programs.

[67] Inactivated Rabies Virus-Vectored Immunocontraceptive Vaccine in a Thermo-Responsive Hydrogel Induces High and Persistent Antibodies against Rabies, but Insufficient Antibodies against Gonadotropin-Releasing Hormone for Contraception.

[68] Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets.

[69] Development of novel subunit vaccine based on truncated fiber protein of egg drop syndrome virus and its immunogenicity in chickens.

[70] Felis catus papillomavirus type 2 virus-like particle vaccine is safe and immunogenic but does not reduce FcaPV-2 viral loads in adult cats

[71] A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice

[72] The future of vaccine development.

[73] AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region.

[74] Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.

[75] A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.

[76] Dangerous agent or saviour? HPV vaccine representations on online discussion forums in Romania.

[77] A qualitative study of vaccination behaviour amongst female Polish migrants in Edinburgh, Scotland.

[78] It's not all about autism: The emerging landscape of anti-vaccination sentiment on Facebook.

[79] Oral cholera vaccination in hard-to-reach communities, Lake Chilwa, Malawi.

[80] Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016

[81] A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.

[82] Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach

[83] A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits

[84] Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay

[85] Student agreement regarding adequacy of didactic content and practical experiences of vaccination clinic business operations.

[86] Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

[87] Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.

[88] Alginate-chitosan coated layered double hydroxide nanocomposites for enhanced oral vaccine delivery.

[89] Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine

[90] Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity

[91] Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses

[92] Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis.

[93] An HRM Assay to Differentiate Sheeppox Virus Vaccine Strains from Sheeppox Virus Field Isolates and other Capripoxvirus Species

[94] Finding Reasons for Vaccination Hesitancy: Evaluating Semi-Automatic Coding of Internet Discussion Forums.

[95] Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review

[96] Knowledge, attitudes and practices of young people in Zimbabwe on cervical cancer and HPV, current screening methods and vaccination.

[97] Induction of Immune Response in Animal Model Using Recombinant Anti-NDV Vaccine.

[98] Vaccine financing in Nigeria: are we making progress towards self-financing/sustenance?

[99] Current status and future prospects for the development of substance abuse vaccines.

[100] Economic impact of contagious caprine pleuropneumonia and cost-benefit analysis of the vaccination programmes based on a one-year continuous monitoring of flocks in the arid and semi-arid lands of Kenya.

[101] One of the recent attacks of smallpox in Europe: A massive vaccination campaign during the epidemic in Wrocław in 1963.